Noile-Immune Biotech Inc.

4893 TSE Pharmaceuticals Pharmaceutical
TSE Growth
¥139.00
-1.42%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

✓Strengths

  • Low debt: debt-to-equity of 0.02.
  • Current assets comfortably cover current liabilities (current ratio 53.54).

!Watch-points

  • Return on equity is on the lower side at -20.2%.
  • Return on capital employed is on the lower side at -20.3%.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
-0.93

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥60億
Current Price¥ 139.00
High / Low¥ 217.00 / 114.00
Stock P/E-7.58
Book Value¥ 90.65
Dividend Yield0%
ROCE-20.25%
ROE-20.22%
Debt to Equity0.02
Current Ratio53.54
P/B Ratio1.6865658
EPS¥ -18.33
Educational data only. Not a recommendation to buy, sell or hold any security.